HERON THERAPEUTICS, INC. /DE/ Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $55.20 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2017-02-23
- HERON THERAPEUTICS, INC. /DE/ valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2016 was $55.20M, a 36.63% increase from fiscal 2015.
- HERON THERAPEUTICS, INC. /DE/ valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2015 was $40.40M, a 26.11% increase from fiscal 2014.
- HERON THERAPEUTICS, INC. /DE/ valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2014 was $32.03M, a 45.36% increase from fiscal 2013.
- HERON THERAPEUTICS, INC. /DE/ valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2013 was $22.04M, a 147.62% increase from fiscal 2012.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2016-12-31 | $55.20M 10-K · filed 2017-02-23 | |
| 2015-12-31 | $40.40M 10-K · filed 2017-02-23 | $40.45M 10-K · filed 2016-02-19 |
| 2014-12-31 | $32.03M 10-K · filed 2016-02-19 | |
| 2013-12-31 | $22.04M 10-K · filed 2015-03-13 | $22.00M 10-K · filed 2014-03-07 |
| 2012-12-31 | $8.90M 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |